New pill combo aims to ease arthritis pain in 60 days

NCT ID NCT07549386

Completed Symptom relief Sponsor: Laboratorios Liomont Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a daily capsule combining etoricoxib and diacerein can reduce pain and improve function in adults with knee or hip osteoarthritis. Over 60 days, 123 participants took either the test combination or an active comparator (meloxicam plus diacerein). Researchers measured pain changes using a standard scale and tracked side effects to compare safety and effectiveness.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: etoricoxib and diacerein combination
What this could lead to: If successful, this could offer a new pain relief option for people with knee or hip osteoarthritis.
What could go wrong: This is a completed Phase 3 trial, but results are not yet published. The combination may not prove more effective or safer than existing treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agnosia osteoarthritis osteoarthritis susceptibility 5 osteoarthritis susceptibility 6

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OSTEOARTHRITIS PAIN MANAGEMENT

Contacts and locations

Locations

Ainpad, S.C.

Morelia, Michoacán, 58350, Mexico
Grupo Médico ASSET, S.C.

Mexico City, Mexico City, 03100, Mexico
Hospital Centro Quirúrgico Nogalar, S.A. de C.V.

Monterrey, Nuevo León, 66484, Mexico
RM Pharma Specialists S.A. de C.V.

Mexico City, Mexico City, 03100, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.